Omicron-specific boosters to roll out in days after CDC signs off

Published



Moderna’s and Pfizer-BioNTech’s updated COVID-19 booster vaccines that target the highly transmittable omicron variant are expected to be ready for rollout in a matter of days after the Centers for Disease Control and Prevention signed off on the updated shots.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.